Anamorelin HCl in the Treatment of Non-Small Cell Lung Cancer-Cachexia (NSCLC-C): An Extension Study (ROMANA 3)
Clinical trial NCT01395914 · COMPLETED
Trial details
- NCT number
- NCT01395914
- Sponsor
- Helsinn Therapeutics (U.S.), Inc
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-07-01
- Primary completion
- 2014-06-01
- Enrollment
- 513
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.